Royalty Pharma Number of noncontrolling interests created remained flat by 0.0% to $4.00 in Q1 2026 compared to the prior quarter.
other_number_of_noncontrolling_interests_created| Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | 3 | 4 | 4 | 4 |
| QoQ Change | — | +33.3% | +0.0% | +0.0% |
| YoY Change | — | — | — | +33.3% |